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RasGRF family guanine nucleotide exchange factors (GEFs) promote guanosine diphosphate (GDP)/guanosine triphos-
phate (GTP) exchange on several Ras GTPases, including H-Ras and TC21. Although the mechanisms controlling RasGRF
function as an H-Ras exchange factor are relatively well characterized, little is known about how TC21 activation is
regulated. Here, we have studied the structural and spatial requirements involved in RasGRF 1/2 exchange activity on
TC21. We show that RasGRF GEFs can activate TC21 in all of its sublocalizations except at the Golgi complex. We also
demonstrate that TC21 susceptibility to activation by RasGRF GEFs depends on its posttranslational modifications:
farnesylated TC21 can be activated by both RasGRF1 and RasGRF2, whereas geranylgeranylated TC21 is unresponsive to
RasGRF2. Importantly, we show that RasGRF GEFs ability to catalyze exchange on farnesylated TC21 resides in its
pleckstrin homology 1 domain, by a mechanism independent of localization and of its ability to associate to membranes.
Finally, our data indicate that Cdc42-GDP can inhibit TC21 activation by RasGRF GEFs, demonstrating that Cdc42
negatively affects the functions of RasGRF GEFs irrespective of the GTPase being targeted.
INTRODUCTION
Ras family GTPases regulate key cellular processes, includ-
ing proliferation, differentiation, and cell survival (Takai et
al., 2001), and their constitutive activation, resulting from
point mutations, underlies severe pathologies such as can-
cer. Apart from the classical Ras proteins: H-Ras, N-Ras, and
K-Ras, another family member frequently found mutated in
human cancers is TC21 (Chan et al., 1994; Huang et al., 1995;
Barker and Crompton, 1998). TC21 belongs to the R-Ras
subfamily and displays an overall 55% homology with the
classical Ras proteins, including identical core effector re-
gions (Drivas et al., 1990). As a consequence, TC21 shares
most effectors with the classical Ras proteins. These include
Raf (Movilla et al., 1999; Rosario et al., 1999), phosphatidyl-
inositol 3-kinase (Rosario et al., 2001; Murphy et al., 2002),
Ral-GDS (Lopez-Barahona et al., 1996; Rosario et al., 2001),
and phospholipase C (Kelley et al., 2004). In contrast, TC21
possesses a unique C-terminal CAAX box, which determines
that TC21 can be both farnesylated and geranylgeranylated
(Carboni et al., 1995; Roskoski and Ritchie, 1998; Reid et al.,
2004), unlike the classical Ras proteins that are farnesylated
(Seabra, 1998). In addition, and also unlike Ras proteins, the
TC21 C terminus does not harbor a polybasic sequence nor
it is clear still whether it can be palmitoylated like R-Ras
(Furuhjelm and Peranen, 2003) These divergences in the
nature of the anchors by which small GTPases associate to
different membrane systems and microdomains (Rocks et al.,
2006) may result in TC21 subcellular distribution being dif-
ferent from that exhibited by Ras, an aspect of TC21 biology
yet unknown.
Ras GTPases cycle between guanosine diphosphate
(GDP)-bound inactive states and guanosine triphosphate
(GTP)-bound active states. The transit from inactive to active
is catalyzed by proteins known as guanine nucleotide ex-
change factors (GEFs). TC21 and Ras become activated by
similar stimuli. Concomitantly, they share several GEFs:
those belonging to the RasGRF and RasGRP but not to the
SOS families (Ohba et al., 2000). The RasGRF family includes
RasGRF1 and RasGRF2, which display a 75% homology
(Fam et al., 1997; Fan et al., 1998; de Hoog et al., 2000). The
primary structures of these GEFs reveal several motifs pre-
sumably involved in diverse regulatory mechanisms. These
include a Dbl homology (DH) domain, mainly present in
GEFs for Rho family GTPases flanked by two pleckstrin
homology (PH) domains of largely unknown function, al-
though suggested to play a role in targeting mechanisms
(Schmidt and Hall, 2002). Interestingly, whereas RasGRF2
does not require its DH domain to activate Ras (de Hoog et
al., 2000), RasGRF1 does (Arozarena et al., 2000). Despite
their high degree of homology, other functional differences
have been reported between RasGRF1 and -2 with respect to
their specificity toward cognate GTPases. Contrarily to
RasGRF1, RasGRF2 cannot activate R-Ras (Gotoh et al.,
2001). Alternatively, RasGRF2 promotes nucleotide ex-
change on H-, N-, and K-RasB in vivo (de Hoog et al., 2000;
Matallanas et al., 2003), whereas RasGRF1 only activates
H-Ras (Jones and Jackson, 1998; Matallanas et al., 2003). Thus
far, it is not known whether, like RasGRF1 (Ohba et al.,
2000), RasGRF2 can activate TC21.
Regarding their regulation, RasGRF1 and -2 are mainly
activated by G protein-coupled receptors and by some ty-
rosine kinase receptors (Shou et al., 1995; Mattingly and
Macara, 1996; Zippel et al., 1996; Fam et al., 1997; Krapivinsky et
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al., 2003; Tian et al., 2004; Robinson et al., 2005). RasGRFs are
also particularly sensible to changes in calcium levels, by a
mechanism mediated through a calmodulin-binding isole-
ucine-glutamine (IQ) domain present in the N terminus of
these GEFs (Farnsworth et al., 1995; Buchsbaum et al., 1996;
Fam et al., 1997; Fan et al., 1998). Furthermore, we have
demonstrated that RasGRFs competence to activate Ras is
regulated by the Rho family GTPase Cdc42, by yet un-
known mechanisms that require a functional DH domain
(Arozarena et al., 2000, 2001). In addition, RasGRF GEFs
exhibit a marked spatial specificity toward pools of Ras
present at distinct membrane systems, being active on Ras at
the plasma membrane and at the endoplasmic reticulum but
not at the Golgi complex (Arozarena et al., 2004).
In this study, we have investigated the mechanisms reg-
ulating TC21 activation by RasGRF family GEFs. We show
that RasGRF GEFs display similar spatial specificities to-
ward TC21 and Ras. We also demonstrate that RasGRFs are
capable of activating TC21 by a mechanism regulated by the
isoprenoid attached to the GTPase and, unlike Ras, are de-
pendent on an integral PH1 domain. Overall, our results
disclose divergences and similarities on the structural and
spatial determinants regulating RasGRF GEFs activity to-
ward closely related GTPases.
MATERIALS AND METHODS
Plasmids
Plasmids encoding RasGRF1 mutants have been described previously
(Buchsbaum et al., 1996; Freshney et al., 1997; Arozarena et al., 2000), those for
RasGRF2 mutants were provided by M. F. Moran (University of Toronto; de
Hoog et al., 2000). pCEFL-HA-TC21 and pCEFL-HA-R-Ras were generated by
subcloning in-frame wild-type TC21 and wild-type R-Ras in pCEFL-HA.
HA-TC21 F204L and F204S were prepared by polymerase chain reaction
(PCR)-directed mutagenesis and verified by sequencing. pCEFL targeting
vectors harboring the tethering signals: M1, LCK, KDELr, and CD8 have
been described previously (Arozarena et al., 2004; Matallanas et al., 2006).
pCEFL-CAV caveola-tethering vector was generated by cloning nucleotides
252-538 of human caveolin-1 in pCEFL. To generate TC21 site-specific vectors,
HA-TC21 C199S was prepared by PCR-directed mutagenesis. It was then
subcloned in-frame into the targeting vectors. Sequences of the oligonucleo-
tides used are available upon request. pCEFL-FLAG-Cdc42 was provided by
Y. Zheng (University of Cincinnati). HA-Cdc42-GAP by R. Cerione. Human
RasGRF2 small interfering RNA (siRNA) and control siRNAs were from Santa
Cruz Biotechnology (Santa Cruz, CA) and used at a concentration of 25 nM.
Cell Culture
COS-7 and HeLa cells were grown in DMEM supplemented with 10% fetal
calf serum. For biochemical analyses, subconfluent COS-7 and HeLa cells
were transfected with DEAE-dextran (Arozarena et al., 2000) and with Lipo-
fectamine (Invitrogen, Carlsbad, CA), respectively. For immunofluorescence
studies, COS-7 and HeLa cells were transfected with FuGENE transfection
reagent (Roche Diagnostics, Mannheim, Germany). Before stimulation, cells
were starved for 18 h, unless otherwise indicated. Lysophosphatidic acid
(LPA) and ionomycin were from Sigma-Aldrich (St. Louis, MO).
Antibodies
Mouse and rabbit monoclonal anti-hemagglutinin (HA), rabbit polyclonal
anti-H-Ras, -early endosome antigen (EEA)1, -panRasGRF, -Sos1, and -extra-
cellular signal-regulated kinase (ERK)2 were from Santa Cruz Biotechnology.
Rabbit polyclonal anti-TC21 was supplied by X. R. Bustelo (University of
Salamanca). Mouse polyclonal anti-protein disulfide isomerase (PDI) was
from Assay Designs (Ann Arbor, MI). Anti-Giantin mouse monoclonal anti-
bodies were supplied by G. Egea (University of Barcelona). Mouse monoclo-
nal anti-transferrin receptor (TFR) was from Zymed Laboratories (South San
Francisco, CA). Rabbit and mouse monoclonal anti-caveolin-1, mouse monoclo-
nal anti-TGN38, -tubulin-, -vinculin, and -paxillin were from BD Biosciences
(San Jose, CA). Mouse monoclonal anti-FLAG was from Sigma-Aldrich.
Ras-GTP Loading Assays
Ras-GTP loading assays were performed as described previously (Arozarena
et al., 2001). H-Ras-GTP, TC21-GTP, and R-Ras-GTP were affinity sequestered
by using glutathione transferase (GST)-Raf-RBD. Immunoblots were per-
formed with anti-HA antibody and quantified by densitometry using Image
1.60 (National Institutes of Health, Bethesda, MD). Activation levels were
related to total protein levels as determined by anti-HA immunoblotting in
the corresponding total lysates. Statistical analyses were performed using
GraphPad software (GraphPad Software, San Diego, CA).
Immunoblotting
Samples were fractionated by SDS-polyacrylamide gel electrophoresis
(PAGE) and transferred onto nitrocellulose filters as described previously
(Ajenjo et al., 2000). Immunocomplexes were visualized by enhanced chemi-
luminescence detection (GE Healthcare, Little Chalfont, Buckinghamshire,
United Kingdom) by using horseradish peroxidase-conjugated secondary
antibodies (Bio-Rad Laboratories, Hercules, CA).
Confocal Immunofluorescence
Cultured cells were washed twice in phosphate-buffered saline (PBS), fixed
with ice-cold 3.7% formaldehyde in PBS for 10 min, and washed with cold
PBS. They were rinsed in PBS-0.05% Tween 20 (Sigma-Aldrich), incubated for
1 h with the primary antibodies or cholera toxin-fluorescein isothiocyanate
(FITC) (Sigma-Aldrich), washed, and incubated for 45 min with the appro-
priate secondary antibodies conjugated to FITC or Texas Red. Coverslips were
mounted in VECTASHIELD (Vector Laboratories, Burlingame, CA), and
sealed. Confocal microscopy was performed with an LSM510 microscope
(Carl Zeiss, Thornwood, NY), by using excitation wavelengths of 488 nm (for
FITC) and 543 nm (for Texas Red).
Sucrose Gradients
Cells were collected and treated as described previously (Matallanas et al.,
2006). In brief, cells were collected and resuspended in 25 mM Tris, pH 7.4,
150 mM NaCl, 5 mM EDTA, and 0.25% Triton X-100. Lysates were set at a
sucrose concentration of 42.5%. Layers of 3.4 ml of 35% sucrose and 1 ml of
16% sucrose were sequentially overlaid and centrifuged for 18 h at 35,000
rpm. Twelve 0.5-ml fractions were collected and precipitated in 6.5% trichlo-
roacetic acid, resuspended in loading buffer, and fractionated by SDS-PAGE.
Nuclei and heavy endomembranes such as the endoplasmic reticulum (ER)
and Golgi, remain in the uncollected pellet.
Subcellular Fractionation
Performed in 20 mM HEPES, pH 7.4, buffer, basically as described previously
(Freshney et al., 1997).
Statistical Analyses
All statistical data were analyzed and compared for statistically significant
differences by Student’s t test (GraphPad Software).
RESULTS
Characterization of the Subcellular Distribution of TC21
As a first step to understand the spatial regulation of TC21
activation, we studied its subcellular distribution. Although
it has been described that overexpressed TC21 localizes in
the ER and the Golgi complex (Ohba et al., 2000), a complete
characterization had never been conducted. Initially, we
attempted to study endogenous TC21 in HeLa cells. How-
ever, neither commercially available nor several house-
made anti-TC21 antibodies yielded satisfactory results. HeLa
cells immunostained with these antibodies exhibited a
highly unspecific, scattered punctuate staining. Similar un-
satisfactory results were obtained in other cells such as
COS-7, BHK, and MCF-7, in which TC21 is expressed at high
levels as ascertained by immunoblotting (data not shown).
As a consequence, we resorted to transient transfections
with minimal amounts of plasmid encoding for HA-TC21.
Such “minimal amount” was decided by extrapolating the
data obtained for H-Ras, cloned in the same expression
vector (pCEFL). In this case, the subcellular distribution of
the exogenous protein can be compared with that of the
endogenous, and we could determine the amounts of plas-
mid for which spillage was not detected (data not shown).
Remarkably, even when transfecting high quantities of HA-
TC21, spillage of the protein was rare. Less than 5% of the
cells showed an abnormal or mislocalized distribution when
transfected with 50 ng of DNA. The percentage increased
just up to 10% when transfected with 500 ng (Supplemental
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Figure 1A). Immunostaining HeLa cells with anti-HA re-
vealed that TC21 displayed mostly a peripheral localization,
with some high-intensity signal at the perinuclear region
and some punctuate cytoplasmic associations (Figure 1,
left). To identify these structures, we performed double
immunofluorescences with specific cellular markers. The
TFR, a disordered membrane marker (Vivien et al., 1993),
disclosed that TC21 was present at these microdomains at
the plasma membrane (PM) and in internal structures, prob-
ably corresponding to recycling endosomes derived from
this type of membrane (Figure 1, A and B), in which TFR has
been observed previously (Mayor et al., 1998). To study the
possible distribution of TC21 in lipid raft regions of the PM,
we stained with cholera toxin-FITC that recognizes the raft
marker GM1, which exhibited a clear colocalization with
TC21 (Figure 1C). Likewise, TC21 also colocalized with the
caveolar marker caveolin-1 (Figure 1D). These results dem-
onstrated that TC21 could locate in all types of PM microdo-
mains. Further proof for the localization of TC21 in the
different microdomains was provided by membrane frac-
tionation experiments, in which cells were solubilized in low
concentrations of Triton X-100 and fractionated in sucrose
gradients. It was found that both endogenous and overex-
pressed TC21 fractionated similarly independently of the
cell type, occurring both in the lighter fractions with the raft
marker caveolin-1 and in disordered membrane fractions,
characterized by the presence of TFR (Supplemental Figure
1B). Continuing with the identification of TC21 localizations,
Figure 1. Subcellular localization of TC21. HeLa cells were transfected with HA-TC21 (100 ng) and its colocalization with site-specific
markers was analyzed by immunofluorescence. (A–N) Representative confocal micrographs of cells doubly immunostained with anti-HA
and anti-TFR (A and B), FITC-cholera toxin (C), anti-caveolin-1 (D), anti-PDI (E), anti-Giantin (F), anti-TGN38 (G), anti-EEA1 (H), Red Nile
(I), anti-paxillin (J), anti-phospho-FAK Y397 (K), phalloidin-Texas Red (L), anti-tubulin- (M), and anti-vimentin (N). Intense colocalization
is shown by arrows. The symbol in the bottom right corner indicates the confocal plane displayed. Bar, 10 m.
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we monitored its distribution in endomembrane systems.
We observed slight colocalization between TC21 and the ER
marker PDI at the perinuclear region (Figure 1E), in which it
also merged with the cis-Golgi marker Giantin (Figure 1F).
In contrast, there was no colocalization with the trans-Golgi
protein TGN38 (Figure 1G), or with the early endosomal
marker EEA1 (Figure 1H), nor did TC21 locate in late endo-
somes, as detected with Red Nile staining (Figure 1I).
It has been reported that R-Ras associates with cytoskel-
etal structures such as focal adhesions (Furuhjelm and
Peranen, 2003), a process determined by its C-terminal do-
main (Wang et al., 2000). Because TC21 possesses motifs
similar to those in R-Ras linked to the formation of focal
adhesions (Clark et al., 1996), we analyzed whether it could
locate in them. We observed a clear colocalization of TC21
with paxillin and with phosphorylated focal adhesion kinase
(FAK), present at these structures (Pendas-Franco et al.,
2007), indicative of its association with focal adhesions (Fig-
ure 1, J and K). TC21 also strongly colocalized with cortical
actin at the cell periphery (Figure 1L), as observed previ-
ously for R-Ras (Holly et al., 2005; Jeong et al., 2005). In
contrast, the internal cytoskeletal distribution of TC21 cor-
responded with tubulin-– and vimentin-positive struc-
tures, indicative of its association with microtubules and
intermediate filaments (Figure 1, M and N). Overall, these
results demonstrated the widespread distribution of TC21 at
various cellular structures and organelles.
RasGRF GEFs Activate TC21 at the Plasma Membrane
and at the Endoplasmic Reticulum
Once we corroborated that TC21 was present at different
localizations, we aimed to analyze whether RasGRF GEFs
activity was restricted to specific regions within the cell. For
that purpose, we generated TC21 constructs that specifically
targeted the GTPase to different membrane platforms. Fol-
lowing the strategy that we had used previously for Ras
(Arozarena et al., 2004; Matallanas et al., 2006), we generated
an unpalmitoylable mutant, TC21 C199S. To this mutant, we
added at its N terminus the cues that would specifically
deliver it to ER (M1 BBV protein), lipid rafts (LCK myris-
toylation signal), Golgi complex (KDELr N193D), and dis-
ordered membrane (CD8 transmembrane domain). All
these targeting signals have been successfully used before
for Ras (Matallanas et al., 2006). An HA tag was also in-
cluded to enable the detection of the expressed proteins. We
desired to analyze TC21 activation also at caveolae. To this
end, we generated CAV-TC21, which harbors at its N-ter-
minus nucleotides 252-538 of human caveolin-1, containing
the transmembrane, oligomerization, and scaffolding do-
mains, required to localize it at caveolae (Song et al., 1997)
(Supplemental Figure 2). All these constructs were tran-
siently expressed in COS-7 cells and their correct distribu-
tion was ascertained by anti-HA immunofluorescence (Fig-
ure 2A). To verify beyond doubt that the targeted TC21
proteins were correctly localized, we also performed frac-
tionations in sucrose gradients. As shown previously for
endogenous TC21, overexpressed wild-type TC21 fraction-
ated in raft and nonraft fractions, whereas LCK- and CAV-
TC21 only fractionated in the lighter fractions and CD8-
TC21 was only detected in the denser fractions, indicative of
their correct localization (Figure 2B). Neither M1- nor
KDELr-TC21 could be detected on either lipid raft or disor-
dered membrane fractions, demonstrating the lack of con-
tamination of peripheral membranes with endomembrane
fragments (data not shown). All these results pointed to the
correct localization of our targeted TC21 proteins.
Previous results from our group showed that RasGRF1/2
activated H-Ras at the PM and the ER but not at the Golgi
complex (Arozarena et al., 2004). It was important to corrob-
orate whether this spatial selectivity was GTPase-specific or
whether it applied to all RasGRFs cognate GTPases. For this
purpose, we cotransfected the tethered TC21 constructs with
RasGRF1 and RasGRF2 in COS-7 cells, which do not express
these GEFs endogenously. TC21 activation was analyzed by
pull-down assays by using GST-Raf-RBD to affinity precip-
itate GTP-bound TC21 (Taylor et al., 2001). We observed that
both GEFs could induce exchange on TC21 in all of the
localizations studied, except for the Golgi complex, in which
RasGRP1 could effectively activate it, as observed previously
for H-Ras (Bivona et al., 2003; Caloca et al., 2003) (Figure 2C).
RasGRF2 was less efficient than RasGRF1 in activating TC21
at the peripheral membrane. This effect was more evident on
lipid raft-tethered TC21 than over disordered membrane
and caveolar TC21. Conversely, both GEFs displayed similar
potentials over ER-tethered M1-TC21 (Figure 2C). These
results demonstrated that RasGRF GEFs show similar spa-
tial selectivity toward their cognate GTPases Ras and TC21.
RasGRF2 Activates Farnesylated but Not
Geranylgeranylated TC21
Because TC21 can be both farnesylated and geranylgerany-
lated (Carboni et al., 1995; Roskoski and Ritchie, 1998; Reid et
al., 2004), we asked whether such difference on its posttrans-
lational modification could affect its activation by RasGRF
GEFs. As a first step, we compared the abilities of the dif-
ferent types of Ras GEFs to stimulate nucleotide exchange
on wild-type TC21. For this, we transfected COS-7 cells with
HA-TC21 plus the different GEFs, and TC21 activation was
analyzed. We observed that RasGRF2 induced nucleotide
exchange on TC21 to a lesser extent than RasGRF1 or Ras-
GRP1 (Figure 3A). In this cellular system, Sos1 showed a
minimal catalytic activity over TC21, contrary to what has
been observed previously in human embryonic kidney 293
cells (Ohba et al., 2000). For comparative reasons, we ascer-
tained that these GEFs induced nucleotide exchange on
H-Ras to similar extents (Figure 3A, middle), whereas over
R-Ras, only RasGRF1 and RasGRP1 could induce GDP/GTP
exchange (Figure 3A, bottom), in complete agreement with
previous reports (Gotoh et al., 1997; Ohba et al., 2000).
It has been reported that RasGRF2 is incapable of activating
R-Ras due to the modification of this GTPase by a geranylgera-
nyl group (Gotoh et al., 2001). Because TC21 can be modified by
either farnesyl-transferases or geranylgeranyl-transferases, it
was possible that RasGRF2 low activity toward TC21 was a
consequence of a predominant geranylgeranylation. To assess
this hypothesis, we generated TC21 mutants modified in their
X amino acid at the CAAX box that directs the posttransduc-
tional modification. Thus, if X is a serine, TC21 F204S, it would
be modified by a farnesyl-transferase, whereas if it is a leucine,
TC21 F204L, a geranylgeranyl group would be added (Reid et
al., 2004). Using these mutants, we observed that farnesylated
TC21 F204S could be activated pronouncedly by RasGRF2,
whereas the geranylgeranylated mutant TC21 F204L was un-
responsive to this GEF (Figure 3B). In contrast, RasGRF1 dis-
played no selectivity toward either form of TC21. These results
demonstrated that RasGRF2 exchange activity over TC21 dis-
plays specificity toward its farnesylated but not its gera-
nylgeranylated form.
The selectivity of RasGRF2 toward TC21 was further ana-
lyzed in HeLa cells, which endogenously express this GEF
(Arozarena et al., 2004). In these, overexpression of RasGRF2
results in an enhanced activation of TC21 even under basal
conditions (Figure 4A). RasGRF GEFs are distinctively acti-
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vated by stimuli mediated by G protein-coupled recep-
tors, such as LPA, and by calcium ionophores, like iono-
mycin (Quilliam et al., 2002). In response to these, TC21 was
markedly activated, and this activation was amply diminished
when the expression of endogenous RasGRF2 was repressed
using a siRNA or after transfection of a dominant-negative
form of the GEF, lacking the Cdc25 domain (Figure 4A). Sim-
ilarly, the selectivity for farnesylated TC21 was also observed
for endogenous RasGRF2: LPA induced a significant activation
of TC21 F204S, which was inhibited when endogenous Ras-
GRF2 was down-regulated either by the siRNA or by the
dominant-negative. By contrast, TC21 F204L was unresponsive
to LPA (Figure 4B). Similar results were obtained in Jurkat
cells, another cellular system that endogenously express Ras-
GRF2 (Ruiz et al., 2007) (data not shown).
Subcellular Distribution of TC21 Is Not Dependent on Its
Isoprenoid Modification
The profound differences on the activity that RasGRF2 dis-
played toward geranylgeranylated and farnesylated TC21
Figure 2. Activation of TC21 by RasGRF GEFs at distinct
membrane platforms. (A) Subcellular localization of site-
specific TC21 proteins. Representative confocal micro-
graphs of COS-7 cells transiently transfected with the
indicated constructs (0.25 g) and immunostained with
anti-HA. Bar, 10 m. (B) Subcellular fractionation of tar-
geted TC21 proteins. COS-7 cells transiently expressing
the different TC21 constructs were solubilized in 0.25%
Triton X-100 and partitioned in a sucrose gradient. The
presence of TC21 in the different fractions was analyzed
by anti-HA immunoblotting. Anti-caveolin-1 immuno-
blotting identified the lipid raft fractions; anti-TFR, the
disordered membrane fractions. (C) Activation of TC21 at
defined sublocalizations. COS-7 cells transfected with
RasGRF GEFs (1 g) in addition to the site-specific TC21
constructs (0.5 g), as indicated. FLAG-RasGRP1 (1 g)
was added in Golgi (Kdel) TC21 activation assays as a
positive control. TC21-GTP levels, present in affinity pre-
cipitates using GST-Raf RBD and total TC21 levels in the
corresponding whole cell lysates (total), were detected by
anti-HA immunoblotting. GEFs levels were detected by
immunoblotting. Figures show the average -fold activa-
tion and p values (NS, p  0.05; *, p  0.05; **, p  0.01;
and ***, p 0.001, with a 95% confidence interval) relative
to control (C) samples of three independent experiments.
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could be a consequence of alterations in the subcellular
localization of this GTPase depending on the prevailing
posttranslational modification. Analyzing the localization of
the different forms of TC21 ectopically expressed in HeLa
cells, we could not observe major differences between the
geranylgeranylated and farnesylated TC21 forms or be-
tween either form and the wild-type GTPase (Figure 5A).
These similar distribution patterns were corroborated in
other settings such as COS-7 cells (Supplemental Figure 3).
The distribution in PM microdomains was further investi-
gated by membrane fractionation. In an identical manner to
endogenous TC21 (Supplemental Figure 1), HA-TC21 was
present both in cholesterol-rich (lipid rafts/caveolae) and in
bulk membrane fractions. The mutant TC21 F204L presented
a similar distribution to wild-type TC21, the same as TC21
F204S, even though it was slightly more enriched in disor-
dered membrane fractions (Figure 5B). Furthermore, by co-
localization immunofluorescence we observed that the dif-
ferent isoprenoid modifications did not alter the degree of
colocalization of TC21 with RasGRF1 and RasGRF2 neither
under basal conditions, nor under stimulation with LPA or
ionomycin (Figure 6 and Supplemental Figure 4). These data
concluded that the different TC21 posttranslational modifi-
cations do not significantly alter its subcellular localization
and, subsequently, RasGRF2 selectivity toward farnesylated
TC21 is not related to its localization.
The PH1 Domain of RasGRF GEFs Is Essential for TC21
Activation
It was of interest to determine which domains in RasGRF
GEFs were implicated in the activation of TC21 and whether
such domains were the same domains involved in the acti-
vation of Ras. For this purpose, we used deletion mutants
for RasGRF1 (Arozarena et al., 2000) and RasGRF2 (de Hoog
et al., 2000) used previously in similar studies on Ras acti-
vation (Figure 7A). In addition, in the case of RasGRF1, we
also used three point mutants: PH1, DH, and IQ, that
contain point mutations that diminish the functionality of
the respective domain without affecting the global structure
of the protein (Buchsbaum et al., 1996; Freshney et al., 1997).
Analyzing the activation of TC21 induced by RasGRF1
domain deletion mutants, we observed that deletion of ei-
ther the PH1 or DH domains clearly affected the catalytic
potential of Ras-GRF1. Similar results were obtained when
we looked at the activation of R-Ras activation (Figure 7B).
However, as demonstrated previously (Arozarena et al.,
2000), this was not the case for H-Ras, which was only
sensitive to the deletion of the DH domain. These results
were ratified when we used the point mutants for the PH1
and DH domains, ruling out gross structural changes as a
possible cause (Figure 7C). In the case of RasGRF2, activa-
tion of TC21 was also dependent on the integrity of the PH1
domain. Similarly to what has been reported previously for
H-Ras activation (de Hoog et al., 2000) and in contrast to
RasGRF1, RasGRF2 DH maintained its exchange potential
over TC21 (Figure 7D).
It was of importance to determine whether RasGRF GEFs
used the same structural domains for inducing exchange on
TC21 subject to different isoprenoid modifications. To this
end, we studied the catalytic potential of RasGRF1/2 dele-
tion mutants over TC21 F204S, farnesylated, and F204L,
geranylgeranylated, variants. Interestingly, the PH1 domain
was fully dispensable for the activation of farnesylated TC21
F204S by both RasGRF1 and RasGRF2. In contrast, both
GEFs required their PH1 domain for inducing exchange on
geranylgeranylated TC21 F204L (Figure 7E). Overall, our
Figure 3. Posttranslational modifications regulate TC21 activation by Ras-
GRF GEFs. (A) Activation of TC21 by Ras GEFs. COS-7 cells were cotrans-
fected with HA-tagged TC21, H-Ras, or R-Ras (0.5 g each) and the indi-
cated GEFs (1 g each). (B) Activation of TC21 mutants F204S and F204L by
Ras GEFs. COS-7 cells were cotransfected with HA-tagged TC21 F204S or
TC21 F204L (0.5 g each) and the indicated GEFs (1 g each). Activated
GTPase levels present in affinity precipitates of GST-Raf RBD and total
GTPase levels in the corresponding whole cell lysates (total) were detected by anti-HA immunoblotting. GEFs levels were detected by
immunoblotting. Figures show the average -fold activation and p value (NS, p  0.05; *, p  0.05; **, p  0.01; and ***, p  0.001, with a 95%
confidence interval) relative to control (C) samples of three independent experiments.
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results demonstrate that RasGRF GEFs structural domain
requirements for the activation of R-Ras GTPases are differ-
ent to those for H-Ras, as a consequence of the particular
isoprenoid modification of this subfamily of GTPases.
LPA- and Ionomycin-induced Activation of TC21
Mediated by RasGRF1 and RasGRF2
The responsiveness of RasGRF GEFs to external stimuli, at
least in H-Ras activation, is dependent on distinct N-termi-
nal domains, both for ionomycin (Buchsbaum et al., 1996;
Freshney et al., 1997; Fan et al., 1998; de Hoog et al., 2000;
Arozarena et al., 2004) and for LPA (Innocenti et al., 1999;
Arozarena et al., 2004). As such, we investigated whether
ionomycin- and LPA-induced potentiation of RasGRF activ-
ity toward TC21 required the same structural domains. To
do so, COS-7 cells were cotransfected with suboptimal con-
centrations of RasGRF1 or RasGRF2 plus HA-TC21, and,
after starvation, TC21 activation was assayed after stimula-
tion. As shown in Figure 8A, at these concentrations neither
RasGRF1 nor RasGRF2 affected TC21 activity. However, for
RasGRF1, both LPA and ionomycin induced an increase in
TC21-GTP levels in the presence of the wild-type GEF, but
the induction was remarkably lower when any of the dele-
tion mutants was the mediator. In RasGRF2, all the deletion
mutants lost their response to ionomycin to great extents,
with the exception of DH that maintained its TC21-activat-
ing capacity. To a lesser extent, these deletion mutants also
displayed a diminished ability to respond to LPA, in partic-
ular IQ (Figure 8B).
In this same context, we also investigated whether some
correlation between the capacity to mediate TC21 nucleotide
exchange and the degree of localization to membranes ex-
isted for the different deletion mutants. Using a simple frac-
tionation protocol, we ascertained the particulate and cyto-
solic content of the RasGRF GEFs mutant forms, under
starvation and upon stimulation with LPA or ionomycin. In
general, we did not observe any remarkable change in the
membranous fraction-bound content for any of the mutant
forms after agonist treatment, which clearly indicated that
their nucleotide exchange potential is not related to their
ability to associate to membranes (Figure 8C). Interestingly,
RasGRF1 and RasGRF2 DH mutants showed the same
distribution, with practically no particulate content, despite
that their abilities to induce GDP/GTP exchange over Ras
and TC21 are completely different. These results demon-
strated that the exchange potential of RasGRF GEFs is not
dependent on its stable association to membranes.
Cdc42 Regulates TC21 Activation by RasGRF GEFs
Past results from our laboratory demonstrated that RasGRF
exchange activity toward H-Ras is negatively regulated by
Cdc42 when GDP-bound (Arozarena et al., 2000, 2001).
Therefore, it was of interest to determine whether this was
also applicable to the activation of TC21. For this purpose,
we used Cdc42-GAP that when overexpressed retains Cdc42
it in its GDP-bound form (Leonard et al., 1998). To begin
with, we used HeLa cells, which harbor endogenous Ras-
GRF2. As shown in Figure 4A, in these cells both LPA and
ionomycin induced a potent TC21 activation, inhibitable by
down-regulation of RasGRF2 levels by an siRNA. The trans-
fection of Cdc42-GAP yielded similar effects as RasGRF2
down-regulation: a pronounced reduction of TC21 activa-
tion (Figure 9A). To further substantiate this observation, we
resorted to our ectopic expression system using COS-7 cells.
We found that TC21 activation as induced by transfected
RasGRF1 or RasGRF2 was largely unaffected by cotrasfected
Figure 4. Agonist-induced activation of TC21
regulated by endogenous RasGRF2. Activation
of TC21 in HeLa cells in response to LPA and
Ionomycin. (upper panels) HeLa cells were
transfected with HA-TC21 (1 g). Where in-
dicated, the concentration of RasGRF2 was
increased by transfection with FLAG-Ras-
GRF2 (1 g) (GRF2) or repressed by an anti-
RasGRF2 siRNA (si). Endogenous RasGRF2
was inhibited by transfecting FLAG-RasGRF2
cdc25 (1 g) (DN). (lower panels) Activation
of HA-TC21 F204S and HA-TC21 F204L, as
described above. For TC21 F204L, RasGRF1 (1
g) was used as a positive control. In all cases,
cells were starved for 18 h and stimulated for 5
min with LPA (10 M) or ionomycin (1 M).
Activated GTPase levels present in affinity pre-
cipitates using GST-Raf RBD and total GTPase
levels in the corresponding whole cell lysates
(total) were detected by anti-HA immunoblot-
ting. GEFs levels were detected by immuno-
blotting. Figures show the average -fold acti-
vation and p values (NS, p  0.05; *, p  0.05;
**, p  0.01; and ***, p  0.001, with a 95%
confidence interval) relative to control (C)/ST
samples of three independent experiments.
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Cdc42-GAP, probably because not sufficient endogenous
Cdc42 is available to counteract the effects of high levels of
RasGRFs. This notion was made clear when wild-type
Cdc42 was transfected in addition to Cdc42-GAP. In this
case, Ras-GRFs-induced TC21 activation was almost abol-
ished (Figure 9B, top). As reported previously (Arozarena et
al., 2000), exogenous Cdc42 per se could inhibit TC21 acti-
vation to a significant extent. Similar results were encoun-
tered when assaying Ras activation as induced by the Ras-
GRF GEFs (Figure 9C, top).
Figure 5. Subcellular distribution of the distinct TC21 forms in
HeLa cells. (A) Representative confocal micrographs of HeLa
cells transiently transfected with HA-TC21, HA-TC21 F204L, HA-
TC21 F204S, HA-R-Ras and HA-H-Ras (0.25 g each). The distri-
bution of the different proteins was detected by specific immu-
nostaining using anti-HA antibodies. Three different confocal
sections are represented in each case. (B) TC21 distribution in PM
microdomains. HeLa cells transiently expressing the different
GTPases were solubilized in 0.25% Triton X-100 and partitioned
in sucrose gradients. The presence of the ectopic proteins in the
different fractions was analyzed by anti-HA immunoblotting.
Anti-caveolin-1 immunoblotting identified the lipid raft frac-
tions, and anti-TFR identified the disordered membrane frac-
tions.
Figure 6. Colocalization of RasGRF1 with TC21. (A–I) Represen-
tative confocal micrographs of COS-7 cells transiently transfected
with RasGRF1 (0.5 g) plus HA-TC21, wild type, or the mutant
forms (0.25 g each), as shown. The distribution of the RasGRF
proteins was detected by specific immunostaining with anti-GRF
antibodies. TC21 was detected with anti-HA antibodies. All micro-
graphs represent equatorial sections at the level of the nucleus.
Intense colocalization is shown by arrows. Cells were subjected to
18-h starvation (ST) and stimulated for 5 min with LPA (10 M) or
ionomycin (1 M), as indicated. Bar, 10 m.
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Figure 7. Structural domains requirements for TC21 activation by RasGRF GEFs. (A) Diagram representing the different RasGRF mutants
used. (B–D) RasGRF1 deletion mutants (B), point mutants (C), and RasGRF2 mutants (D) were tested in their catalytic potential toward TC21.
H-Ras and R-Ras activation also was analyzed where indicated. COS-7 cells were cotransfected with HA-tagged TC21, H-Ras, or R-Ras (0.5
g each) and the indicated RasGRF mutants (1 g each). GTPase activation was determined as described in Materials and Methods. RasGRF
and RasGRF2 mutant levels were detected by anti-GRF and anti-FLAG immunoblotting, respectively. (E) Activation of TC21 F204S and F204L
mutants by RasGRF1 (left) and RasGRF2 (right) deletion mutants. Figures show the average -fold activation and p values (NS, p  0.05; *,
p  0.05; **, p  0.01; and ***, p  0.001, with a 95% confidence interval) relative to control (C) samples of three independent experiments.
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Finally, we tested whether Cdc42-GDP could inhibit Ras-
GRF-induced TC21 activation globally or, in contrast,
whether its effects were restricted to some of the subcellular
localizations where TC21 is present. We explored this pos-
sibility by using the previously described TC21-targeted
constructs. COS-7 cells were transfected with the site-spe-
cific TC21 constructs, the RasGRF GEFs plus Cdc42-GAP
and Cdc42 wild type. We observed that the negative effect of
Cdc42-GDP over site-specific TC21 activation, as induced by
RasGRF1 and RasGRF2, was evident to a significant extent
in all the localizations studied (Figure 9B). Similar effects
were observed on Ras activation (Figure 8C). These results
suggested that the spatial regulation of RasGRF GEFs by
Cdc42-GDP is largely independent of the GTPase being
targeted by the GEFs and of the subcellular localization that
the cognate GTPases occupy.
DISCUSSION
In this study, we have investigated the mechanisms regulat-
ing the activation of TC21 by RasGRF GEFs, paying partic-
ular attention to spatial and structural determinants. Re-
garding subcellular distribution, we have found that TC21 is
Figure 8. Agonist-induced activation of TC21 mediated by RasGRF GEFs does not correlate with PM translocation. (A and B) Activation
of TC21 induced by LPA and ionomycin and mediated by RasGRF1 (A) and RasGRF2 (B) deletion mutants. COS-7 cells were cotransfected
with HA-TC21 (0.5 g) and suboptimal concentrations (0.1 g) of the distinct GEFs. After 18-h starvation, cells were treated with 10 M LPA
or 1 M ionomycin for 5 min. TC21-GTP levels were detected as described previously. Data show mean  SEM of three independent
experiments, relative to the TC21-GTP levels detected in control cells. Expression levels of the different RasGRF1 and RasGRF2 forms were
detected by anti-GRF and anti-FLAG immunoblotting, respectively. (C) Subcellular distribution of RasGRF GEFs under agonist stimulation.
COS-7 cells were treated as described above and fractionated in S100 soluble (S) and P100 particulate (P) fractions. The presence of RasGRF
was revealed by immunoblotting. ERK2 and TFR immunoblots served as controls for the soluble and particulate fractions. Figures show the
percentage of RasGRF present at each fraction, represented as the average of three independent experiments.
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Figure 9. Effects of Cdc42-GDP on TC21 activation induced by RasGRF GEFs. (A) Effects of Cdc42-GDP on agonist-induced TC21 activation
in HeLa cells. HeLa cells were transfected with HA-TC21 (1 g) and HA-Cdc42-GAP (1 g) or an anti-RasGRF2 siRNA (si) where indicated.
Cells were starved for 18 h and stimulated for 5 min with LPA (10 M) or ionomycin (1 M). Activated GTPase levels present in affinity
precipitates of GST-Raf RBD and total GTPase levels in the corresponding whole cell lysates (total) were detected by anti-HA immunoblot-
ting. (B) Site-specific effect of Cdc42-GDP on RasGRF-mediated TC21 activation. COS-7 cells were transfected with RasGRF GEFs (1 g), as
indicated, in addition to HA-TC21 or site-specific HA-TC21 constructs (0.5 g), in addition to empty vector (), 0.5 g of FLAG-Cdc42 (),
and 0.5 g of HA-Cdc42-GAP (), as indicated. TC21 activation was determined as described in Materials and Methods. RasGRF, Cdc42, and
Cdc42-GAP levels were detected by immunoblotting. (C) Site-specific effect of Cdc42-GDP on RasGRF-mediated H-Ras activation. Figures
show the average -fold activation relative to control samples of three independent experiments.
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widespread in most membrane systems. Previous studies
reported TC21 presence at the ER, Golgi (Ohba et al., 2000),
and caveolin-rich fractions (Lisanti et al., 1994). At the Golgi,
we show that TC21 locates solely in the cis-Golgi network.
Like other GTPases, such as H-Ras and R-Ras (Choy et al.,
1999; Furuhjelm and Peranen, 2003), TC21 could use the
exocytic route to reach its PM destinations. Interestingly, we
did not detect TC21 in early and late endosomes, suggesting
that TC21 may not be internalized, at least through the type
of endosomes marked by these stains, because it can be
found in cytoplasmic vesicles rich in TFR. Further studies
are required to clarify this. In addition, we report TC21
association with focal adhesions, in accordance with its
known participation in integrin signaling (Keely et al., 1999;
Hansen et al., 2003). TC21 also colocalized with cortical actin
at the cell periphery, as observed previously for R-Ras
(Holly et al., 2005; Jeong et al., 2005). We have also found
TC21 colocalizing with microtubules and intermediate fila-
ments, further supporting its role in the regulation of the
cytoskeleton and its participation in related functions such
as adhesion, migration, and invasion (Clark et al., 1996;
Keely et al., 1999; Huang et al., 2004; Arora et al., 2005; Jeong
et al., 2005; Pozzi et al., 2006).
We show that RasGRF2 can induce nucleotide exchange
on TC21, although to a lesser extend than RasGRF1 or Ras-
GRP1, known previously to activate GTPases of the R-Ras
family (Gotoh et al., 1997; Ohba et al., 2000; Quilliam et al.,
2002). As shown previously (Gotoh et al., 2001), RasGRF2
was incapable of inducing the activation of R-Ras, probably
as a result of the characteristic geranylgeranylation of this
GTPase. In a similar manner, RasGRF2 inability to activate
TC21 could be a consequence of the predominant gera-
nylgeranylation of TC21 in the cellular system used in our
studies. We have confirmed this hypothesis by showing that
TC21 F204L, exclusively geranylgeranylated, is refractory to
nucleotide exchange in response to RasGRF2, as opposed to
the farnesylated F204S mutant, which can be potently acti-
vated by this GEF. These observations reinforce the notion
that RasGRF2 activity is critically dependent on the post-
translational modifications suffered by its cognate GTPases.
Although this isoprenoid-dependent regulation was origi-
nally described in R-Ras (Gotoh et al., 2001), its physiological
relevance was limited, because R-Ras is not naturally farne-
sylated (Reid et al., 2004), unlike TC21 that can be both
farnesylated and geranylgeranylated (Roskoski and Ritchie,
1998; Reid et al., 2004). Thus, in a given tissue, the ratio
between GGTs and FTs could exert a regulatory role on
signal specificity by dictating the predominant isoprenoid
modification in TC21 and thereby its susceptibility to Ras-
GRF2 action. Tissue-specific differences in GGTs/FTs rela-
tive activities have been described previously (Morris and
Pullarkat, 1995). This study also reported that brain white
matter exhibits higher FTase activity than gray matter, sug-
gesting a region-specific susceptibility of TC21 to RasGRF2
in a brain area in which RasGRFs are particularly enriched
(Zippel et al., 1997). Another example of such regulation
would be RhoB, which can be either farnesylated or gera-
nylgeranylated (Adamson et al., 1992); it suppresses trans-
formation only when geranylgeranylated (Mazieres et al.,
2005).
With respect to spatial regulation, our results demonstrate
that TC21 activation by RasGRF GEFs occurs in all mem-
brane platforms except for the Golgi complex, with a similar
situation reported for H-Ras (Arozarena et al., 2004; Ruiz et
al., 2007). Apparently, the isoprenoid modifying TC21 is not
relevant for its subcellular localization, because the wild-
type form and both F204S and F204L mutants display sim-
ilar distributions. Probably, the distribution of R-Ras GT-
Pases is more dependent on their core C-terminal domains,
which in R-Ras determine its association to focal adhesions
(Furuhjelm and Peranen, 2003), cortical actin filaments
(Jeong et al., 2005), and lipid rafts (Hansen et al., 2003). These
results suggest that TC21 isoprenoid-dependent susceptibil-
ity to activation by RasGRF2 is not, in general, related to
changes in spatial distribution but rather, probably depends
on structural restraints, such as those described in R-Ras
(Gotoh et al., 2001). When analyzing the space-related acti-
vation of TC21 elicited by RasGRF GEFs, we observed that it
is most prominent at PM microdomains than at endomem-
branes. Also, RasGRF1 is a better activator in most localiza-
tions, with the exception of the ER in which its ability to
induce GDP/GTP exchange on TC21 is similar to RasGRF2.
The mechanisms underlying in these variations are un-
known, although they could be related to RasGRF1 and -2
having different capacities for accessing distinct membrane
platforms.
We have characterized the structural domains in RasGRF
GEFs necessary for TC21 activation. Interestingly, both Ras-
GRF1 and RasGRF2 require their PH1 domain for inducing
exchange on TC21 and R-Ras. More interestingly, this PH1
dependence seems to be restricted to the activation of gera-
nylgeranylated GTPases because it was not observed in
H-Ras or farnesylated TC21. One possibility is that the PH1
domain is required for RasGRF GEFs to reach microdomains
in which geranylgeranylated GTPases reside. A second pos-
sibility is that the PH1 domain somehow mediates in the
direct interaction of RasGRF GEFs with geranylgeranylated
but not farnesylated GTPases. In addition, RasGRF1 also
requires its DH domain for activating TC21. This depen-
dence was not observed for RasGRF2, in spite of an 85%
homology between both DH domains (Fam et al., 1997). A
similar situation has been reported for H-Ras (Arozarena et
al., 2000; de Hoog et al., 2000).
Regarding external agonists, we show that LPA and iono-
mycin potentiate RasGRF GEFs activity on TC21. Both stim-
uli have been shown to enhance H-Ras (Farnsworth et al.,
1995; Zippel et al., 2000) and R-Ras activation (Gotoh et al.,
1997) by RasGRF1. These also induced a significant Ras-
GRF2-mediated activation of TC21, despite its low basal
activity toward this GTPase. All RasGRF N-terminal regu-
latory domains are required to some extent for TC21 ago-
nist-induced activation, similarly to what has been reported
for H-Ras (Buchsbaum et al., 1996; Freshney et al., 1997; Fan
et al., 1998; Innocenti et al., 1999; de Hoog et al., 2000;
Arozarena et al., 2004). Noticeably, we have observed that
agonist-induced activation of RasGRFs does not entail gross
changes in the direct association of the GEFs to membranes.
Furthermore, we have observed that RasGRF functions are
not dependent on its stable association to membranes, be-
cause PH1 mutants, with low TC21-GEF activity, display a
membrane association similar to wild-type proteins, whereas
RasGRF1 and RasGRF2 DH mutants, showing opposed ac-
tivities toward H-Ras and TC21, exhibit an identical distribu-
tion, being absent from the particulate fraction.
Finally, we have investigated the role of Cdc42 in the
regulation of TC21 activation by RasGRFs. Cdc42 in its
GDP-bound form inhibits RasGRF1-mediated activation of
H-Ras (Arozarena et al., 2000, 2001; Rabiet et al., 2002). We
have observed that, similarly to H-Ras, a Cdc42-GAP dimin-
ishes RasGRF1 and RasGRF2 exchange activity on TC21, an
effect observable at all of its sublocalizations. Even though
the mechanism whereby Cdc42-GDP inhibits RasGRFs func-
tions is still unclear, these results demonstrate that it affects
all cognate GTPases and is, to a large extent, localization
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independent. In contrast to what was proposed previously,
that Cdc42-GDP prevented H-Ras activation by inhibiting
RasGRF1 translocation to membranes (Arozarena et al.,
2000), here we demonstrate that stable association to mem-
branes is not essential for RasGRFs being functional. Thus,
Cdc42 could somehow regulate GEFs access to the proximity
of membranes, where the interaction with cognate GTPases
would ensue. Further experimentation is required to prove
this point.
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